Multiplexed mass spectrometry monitoring of biomarker candidates for osteoarthritis

Journal of Proteomics

Volumn 152, Issue , 2017, Pages 216-225

  Fernández Puente, Patricia ^a   Calamia, Valentina ^a   González Rodríguez, Lucía ^a   Lourido, Lucía ^a   Camacho Encina, María ^a   Oreiro, Natividad ^a   Ruiz Romero, Cristina ^a,b   Blanco, Francisco J ^a,c  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c Medical Oncology Unit CHUAC SERGAS   (Spain)

Author keywords

Biomarkers; Cartilage; Chondrocytes; Osteoarthritis; Serum; SRM MRM; Synovial fluid

Indexed keywords

BIOLOGICAL MARKER; HAPTOGLOBIN; PROTEIN; VON WILLEBRAND FACTOR; PEPTIDE;

AGED; ARTICLE; ARTICULAR CARTILAGE; BLOOD SAMPLING; CARTILAGE; CHONDROCYTE; CHROMOSOME 16; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIQUID CHROMATOGRAPH; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETER; MASS SPECTROMETRY; MULTIPLE REACTION MONITORING; MULTIPLEXED MASS SPECTROMETRY; OSTEOARTHRITIS; PRIORITY JOURNAL; SYNOVIAL FLUID; BLOOD; CASE CONTROL STUDY; CELL LINE; CHEMISTRY; DISEASE EXACERBATION; PATHOLOGY; PROCEDURES; SPECIMEN HANDLING;

BIOMARKERS; CARTILAGE, ARTICULAR; CASE-CONTROL STUDIES; CELL LINE; CHONDROCYTES; CHROMOSOMES, HUMAN, PAIR 16; DISEASE PROGRESSION; HUMANS; MASS SPECTROMETRY; OSTEOARTHRITIS; PEPTIDES; SPECIMEN HANDLING; SYNOVIAL FLUID;

EID: 84998579393     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2016.11.012     Document Type: Article

References (56)

1. [1] Segura, V., Medina-Aunon, J.A., Mora, M.I., Martinez-Bartolome, S., Abian, J., Aloria, K., et al. Surfing transcriptomic landscapes. A step beyond the annotation of Chromosome 16 proteome. J. Proteome Res. 13 (2014), 158–172.
2. [2] Ruiz-Romero, C., Calamia, V., Albar, J.P., Casal, J.I., Corrales, F.J., Fernandez-Puente, P., et al. The Spanish biology/disease initiative within the human proteome project: application to rheumatic diseases. J. Proteome 127 (2015), 406–413.
3. [3] Cooper, C., Adachi, J.D., Bardin, T., Berenbaum, F., Flamion, B., Jonsson, H., et al. How to define responders in osteoarthritis. Curr. Med. Res. Opin. 29 (2013), 719–729.
4. [4] Hunter, D.J., Nevitt, M., Losina, E., Kraus, V., Biomarkers for osteoarthritis: current position and steps towards further validation. Best Pract. Res. Clin. Rheumatol. 28 (2014), 61–71.
5. [5] Kraus, V.B., Blanco, F.J., Englund, M., Karsdal, M.A., Lohmander, L.S., Call for standardized definitions of osteoarthritis and risk stratification for clinical trials and clinical use. Osteoarthr. Cartil. 23 (2015), 1233–1241.
6. [6] Ruiz-Romero, C., Fernandez-Puente, P., Calamia, V., Blanco, F.J., Lessons from the proteomic study of osteoarthritis. Expert Rev. Proteomics 12 (2015), 433–443.
7. [7] Lotz, M., Martel-Pelletier, J., Christiansen, C., Brandi, M.L., Bruyere, O., Chapurlat, R., et al. Value of biomarkers in osteoarthritis: current status and perspectives. Ann. Rheum. Dis. 72 (2013), 1756–1763.
8. [8] Aebersold, R., Bader, G.D., Edwards, A.M., van Eyk, J.E., Kussmann, M., Qin, J., et al. The biology/disease-driven human proteome project (B/D-HPP): enabling protein research for the life sciences community. J. Proteome Res. 12 (2013), 23–27.
9. [9] Ritter, S.Y., Subbaiah, R., Bebek, G., Crish, J., Scanzello, C.R., Krastins, B., et al. Proteomic analysis of synovial fluid from the osteoarthritic knee: comparison with transcriptome analyses of joint tissues. Arthritis Rheum. 65 (2013), 981–992.
10. [10] Henjes, F., Lourido, L., Ruiz-Romero, C., Fernandez-Tajes, J., Schwenk, J.M., Gonzalez-Gonzalez, M., et al. Analysis of autoantibody profiles in osteoarthritis using comprehensive protein array concepts. J. Proteome Res. 13 (2014), 5218–5229.
11. [11] Fernandez-Puente, P., Mateos, J., Fernandez-Costa, C., Oreiro, N., Fernandez-Lopez, C., Ruiz-Romero, C., et al. Identification of a panel of novel serum osteoarthritis biomarkers. J. Proteome Res. 10 (2011), 5095–5101.
12. [12] Finger, F., Schorle, C., Zien, A., Gebhard, P., Goldring, M.B., Aigner, T., Molecular phenotyping of human chondrocyte cell lines T/C-28a2, T/C-28a4, and C-28/I2. Arthritis Rheum. 48 (2003), 3395–3403.
13. [13] Altman, R., Asch, E., Bloch, D., Bole, G., Borenstein, D., Brandt, K., et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum. 29 (1986), 1039–1049.
14. [14] Kessler, S., Guenther, K.P., Puhl, W., Scoring prevalence and severity in gonarthritis: the suitability of the Kellgren & Lawrence scale. Clin. Rheumatol. 17 (1998), 205–209.
15. [15] Bradford, M.M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976), 248–254.
16. [16] Desjardins, P., Hansen, J.B., Allen, M., Microvolume protein concentration determination using the NanoDrop 2000c spectrophotometer. J. Vis. Exp., 2009.
17. [17] MacLean, B., Tomazela, D.M., Shulman, N., Chambers, M., Finney, G.L., Frewen, B., et al. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics 26 (2010), 966–968.
18. [18] Craig, R., Cortens, J.P., Beavis, R.C., Open source system for analyzing, validating, and storing protein identification data. J. Proteome Res. 3 (2004), 1234–1242.
19. [19] Percy, A.J., Simon, R., Chambers, A.G., Borchers, C.H., Enhanced sensitivity and multiplexing with 2D LC/MRM-MS and labeled standards for deeper and more comprehensive protein quantitation. J. Proteome 106 (2014), 113–124.
20. [20] Ruiz-Romero, C., Carreira, V., Rego, I., Remeseiro, S., Lopez-Armada, M.J., Blanco, F.J., Proteomic analysis of human osteoarthritic chondrocytes reveals protein changes in stress and glycolysis. Proteomics 8 (2008), 495–507.
21. [21] Lourido, L., Calamia, V., Mateos, J., Fernandez-Puente, P., Fernandez-Tajes, J., Banco, F.J., et al. Quantitative proteomic profiling of human articular cartilage degradation in osteoarthritis. J. Proteome Res. 13 (2014), 6096–6106.
22. [22] Mateos, J., Lourido, L., Fernández-Puente, P., Calamia, V., Fernández-López, C., Oreiro, N., et al. Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using LC-MALDI TOF/TOF. J. Proteome 75 (2012), 2869–2878.
23. [23] Fernandez-Costa, C., Calamia, V., Fernandez-Puente, P., Capelo-Martinez, J.-L., Ruiz-Romero, C., Blanco, F.J., Sequential depletion of human serum for the search of osteoarthritis biomarkers. Proteome Sci., 10, 2012, 55.
24. [24] Calamia, V., Rocha, B., Mateos, J., Fernandez-Puente, P., Ruiz-Romero, C., Blanco, F.J., Metabolic labeling of chondrocytes for the quantitative analysis of the interleukin-1-beta-mediated modulation of their intracellular and extracellular proteomes. J. Proteome Res. 10 (2011), 3701–3711.
25. [25] Wang, Q., Rozelle, A.L., Lepus, C.M., Scanzello, C.R., Song, J.J., Larsen, D.M., et al. Identification of a central role for complement in osteoarthritis. Nat. Med. 17 (2011), 1674–1679.
26. [26] Blankley, R.T., Fisher, C., Westwood, M., North, R., Baker, P.N., Walker, M.J., et al. A label-free selected reaction monitoring workflow identifies a subset of pregnancy specific glycoproteins as potential predictive markers of early-onset pre-eclampsia. Mol. Cell. Proteomics 12 (2013), 3148–3159.
27. [27] Carr, S.A., Abbatiello, S.E., Ackermann, B.L., Borchers, C., Domon, B., Deutsch, E.W., et al. Targeted peptide measurements in biology and medicine: best practices for mass spectrometry-based assay development using a fit-for-purpose approach. Mol. Cell. Proteomics 13 (2014), 907–917.
28. [28] Aguilar-Mahecha, A., Kuzyk, M.A., Domanski, D., Borchers, C.H., Basik, M., The effect of pre-analytical variability on the measurement of MRM-MS-based mid- to high-abundance plasma protein biomarkers and a panel of cytokines. PLoS One, 7, 2012, e38290.
29. [29] Lopez, M.F., Rezai, T., Sarracino, D.A., Prakash, A., Krastins, B., Athanas, M., et al. Selected reaction monitoring-mass spectrometric immunoassay responsive to parathyroid hormone and related variants. Clin. Chem. 56 (2010), 281–290.
30. [30] Percy, A.J., Chambers, A.G., Smith, D.S., Borchers, C.H., Standardized protocols for quality control of MRM-based plasma proteomic workflows. J. Proteome Res. 12 (2013), 222–233.
31. [31] Percy, A.J., Yang, J., Chambers, A.G., Simon, R., Hardie, D.B., Borchers, C.H., Multiplexed MRM with internal standards for cerebrospinal fluid candidate protein biomarker quantitation. J. Proteome Res. 13 (2014), 3733–3747.
32. [32] Chambers, A.G., Percy, A.J., Yang, J., Borchers, C.H., Multiple reaction monitoring enables precise quantification of 97 proteins in dried blood spots. Mol. Cell. Proteomics 14 (2015), 3094–3104.
33. [33] Wehr, A.Y., Hwang, W.T., Blair, I.A., Yu, K.H., Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry. J. Proteome Res. 11 (2012), 1749–1758.
34. [34] Tsunezumi, J., Higashi, S., Miyazaki, K., Matrilysin (MMP-7) cleaves C-type lectin domain family 3 member A (CLEC3A) on tumor cell surface and modulates its cell adhesion activity. J. Cell. Biochem. 106 (2009), 693–702.
35. [35] Chambers, A.G., Percy, A.J., Hardie, D.B., Borchers, C.H., Comparison of proteins in whole blood and dried blood spot samples by LC/MS/MS. J. Am. Soc. Mass Spectrom. 24 (2013), 1338–1345.
36. [36] Kennedy, J.J., Abbatiello, S.E., Kim, K., Yan, P., Whiteaker, J.R., Lin, C., et al. Demonstrating the feasibility of large-scale development of standardized assays to quantify human proteins. Nat. Methods 11 (2014), 149–155.
37. [37] Brownridge, P., Beynon, R.J., The importance of the digest: proteolysis and absolute quantification in proteomics. Methods 54 (2011), 351–360.
38. [38] Arsene, C.G., Ohlendorf, R., Burkitt, W., Pritchard, C., Henrion, A., O'Connor, G., et al. Protein quantification by isotope dilution mass spectrometry of proteolytic fragments: cleavage rate and accuracy. Anal. Chem. 80 (2008), 4154–4160.
39. [39] Kamiie, J., Ohtsuki, S., Iwase, R., Ohmine, K., Katsukura, Y., Yanai, K., et al. Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria. Pharm. Res. 25 (2008), 1469–1483.
40. [40] Gutteridge, J.M., The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim. Biophys. Acta 917 (1987), 219–223.
41. [41] Nielsen, M.J., Moestrup, S.K., Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 114 (2009), 764–771.
42. [42] Arredouani, M., Matthijs, P., Van Hoeyveld, E., Kasran, A., Baumann, H., Ceuppens, J.L., et al. Haptoglobin directly affects T cells and suppresses T helper cell type 2 cytokine release. Immunology 108 (2003), 144–151.
43. [43] Kume, H., Muraoka, S., Kuga, T., Adachi, J., Narumi, R., Watanabe, S., et al. Discovery of colorectal cancer biomarker candidates by membrane proteomic analysis and subsequent verification using selected reaction monitoring (SRM) and tissue microarray (TMA) analysis. Mol. Cell. Proteomics 13 (2014), 1471–1484.
44. [44] Ritter, S.Y., Collins, J., Krastins, B., Sarracino, D., Lopez, M., Losina, E., et al. Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis. Arthritis Res. Ther., 16, 2014, 456.
45. [45] Hsueh, M.F., Onnerfjord, P., Kraus, V.B., Biomarkers and proteomic analysis of osteoarthritis. Matrix Biol. 39c (2014), 56–66.
46. [46] Lenting, P.J., Casari, C., Christophe, O.D., Denis, C.V., Von Willebrand factor: the old, the new and the unknown. J. Thromb. Haemost. 10 (2012), 2428–2437.
47. [47] Ohshima, S., Kuchen, S., Seemayer, C.A., Kyburz, D., Hirt, A., Klinzing, S., et al. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum. 48 (2003), 2788–2795.
48. [48] Pfander, D., Cramer, T., Deuerling, D., Weseloh, G., Swoboda, B., Expression of thrombospondin-1 and its receptor CD36 in human osteoarthritic cartilage. Ann. Rheum. Dis. 59 (2000), 448–454.
49. [49] Duncan, M.W., Yergey, A.L., Patterson, S.D., Quantifying proteins by mass spectrometry: the selectivity of SRM is only part of the problem. Proteomics 9 (2009), 1124–1127.
50. [50] Muttigi, M.S., Han, I., Park, H.K., Park, H., Lee, S.H., Matrilin-3 role in cartilage development and osteoarthritis. Int. J. Mol. Sci., 17, 2016, 590.
51. [51] Klatt, A.R., Paul-Klausch, B., Klinger, G., Hillebrand, U., Kuhn, G., Kobbe, B., et al. The matrilin-3 VWA1 domain modulates interleukin-6 release from primary human chondrocytes. Osteoarthr. Cartil. 21 (2013), 869–873.
52. [52] Nakajima, M., Miyamoto, Y., Ikegawa, S., Cloning and characterization of the osteoarthritis-associated gene DVWA. J. Bone Miner. Metab. 29 (2011), 300–308.
53. [53] Zhang, R., Yao, J., Xu, P., Ji, B., Voegeli, G., Hou, W., et al. Association between genetic variants of DVWA and osteoarthritis of the knee and hip: a comprehensive meta-analysis. Int. J. Clin. Exp. Med. 8 (2015), 9430–9437.
54. [54] Wang, T., Liang, Y., Li, H., He, Q., Xue, Y., Shen, C., et al. Single nucleotide polymorphisms and osteoarthritis: an overview and a meta-analysis. Medicine (Baltimore), 95, 2016, e2811.
55. [55] Veselinovic, M., Jakovljevic, V., Jurisic-Skevin, A., Toncev, S., Djuric, D.M., Carotid enlargement and serum levels of von Willebrand factor in rheumatoid arthritis: a follow-up study. Clin. Rheumatol. 31 (2012), 1727–1732.
56. [56] Ogdie, A., Li, J., Dai, L., Paessler, M.E., Yu, X., Diaz-Torne, C., et al. Identification of broadly discriminatory tissue biomarkers of synovitis with binary and multicategory receiver operating characteristic analysis. Biomarkers 15 (2010), 183–190.